Back

Apabetalone, a BET inhibitor, attenuates inflammation induced by viral RNA mimetic and reduces SARS-CoV-2 spike protein binding regardless of variants

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Pericardial disease, myocardial disease, COVID-19 Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Ewelina Kulikowski

Calgary (Canada)

5 More presentations in this session

Presentation thumbnail
Risk of acute myocardial infarction, stroke and thromboembolism following COVID-19 vaccination compared to testing positive for COVID-19 infection: a nationwide cohort study of 4.6 mio individuals
Mr M. Lassen (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers
Doctor M. Radvan (Brno, CZ)
Abstract Slides
Presentation thumbnail
PTX3 as a novel inflammatory biomarker in patients with myocarditis
Doctor A. Villatore (Milan, IT)
Abstract Slides
Presentation thumbnail
Clinical outcome of patients with severe malignant pericardial effusion due to neoplastic disease undergoing percutaneous balloon pericardiotomy during COVID-19 pandemic
Doctor E. Alfonso Rodriguez (Barcelona, ES)
Abstract Slides
Presentation thumbnail
The burden of coronary revascularization associated with lipoprotein(a) in patients with atherosclerotic cardiovascular disease: data from the UK Biobank
Doctor P. Welsh (Glasgow, GB)
Abstract Slides

Access the full session

Session thumbnail
Pericardial disease, myocardial disease, COVID-19

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources